These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 20224549)

  • 1. Phosphatidylinositol-(4,5)-bisphosphate enables efficient secretion of HIV-1 Tat by infected T-cells.
    Rayne F; Debaisieux S; Yezid H; Lin YL; Mettling C; Konate K; Chazal N; Arold ST; Pugnière M; Sanchez F; Bonhoure A; Briant L; Loret E; Roy C; Beaumelle B
    EMBO J; 2010 Apr; 29(8):1348-62. PubMed ID: 20224549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 Tat is unconventionally secreted through the plasma membrane.
    Rayne F; Debaisieux S; Bonhoure A; Beaumelle B
    Cell Biol Int; 2010 Mar; 34(4):409-13. PubMed ID: 19995346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RCAS1 induced by HIV-Tat is involved in the apoptosis of HIV-1 infected and uninfected CD4+ T cells.
    Minami R; Yamamoto M; Takahama S; Miyamura T; Watanabe H; Suematsu E
    Cell Immunol; 2006 Sep; 243(1):41-7. PubMed ID: 17250817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 Tat protein inhibits neurosecretion by binding to phosphatidylinositol 4,5-bisphosphate.
    Tryoen-Tóth P; Chasserot-Golaz S; Tu A; Gherib P; Bader MF; Beaumelle B; Vitale N
    J Cell Sci; 2013 Jan; 126(Pt 2):454-63. PubMed ID: 23178941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclophilin A enables specific HIV-1 Tat palmitoylation and accumulation in uninfected cells.
    Chopard C; Tong PBV; Tóth P; Schatz M; Yezid H; Debaisieux S; Mettling C; Gross A; Pugnière M; Tu A; Strub JM; Mesnard JM; Vitale N; Beaumelle B
    Nat Commun; 2018 Jun; 9(1):2251. PubMed ID: 29884859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular HIV-1 tat protein up-regulates the expression of surface CXC-chemokine receptor 4 in resting CD4+ T cells.
    Secchiero P; Zella D; Capitani S; Gallo RC; Zauli G
    J Immunol; 1999 Feb; 162(4):2427-31. PubMed ID: 9973525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ins and outs of HIV-1 Tat.
    Debaisieux S; Rayne F; Yezid H; Beaumelle B
    Traffic; 2012 Mar; 13(3):355-63. PubMed ID: 21951552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fab'-induced folding of antigenic N-terminal peptides from intrinsically disordered HIV-1 Tat revealed by X-ray crystallography.
    Serrière J; Dugua JM; Bossus M; Verrier B; Haser R; Gouet P; Guillon C
    J Mol Biol; 2011 Jan; 405(1):33-42. PubMed ID: 21035463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural Insights into the Mechanism of HIV-1 Tat Secretion from the Plasma Membrane.
    Ghanam RH; Eastep GN; Saad JS
    J Mol Biol; 2023 Jan; 435(2):167880. PubMed ID: 36370804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1-Tat potentiates CXCL12/stromal cell-derived factor 1-induced downregulation of membrane CXCR4 in T lymphocytes through protein kinase C zeta.
    Hidalgo-Estévez AM; Punzón C; Sanchez-Duffhues G; Muñoz E; Fresno M
    Mol Immunol; 2008 Nov; 46(1):106-15. PubMed ID: 18760839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 Tat modulates T-bet expression and induces Th1 type of immune response.
    Kulkarni A; Ravi DS; Singh K; Rampalli S; Parekh V; Mitra D; Chattopadhyay S
    Biochem Biophys Res Commun; 2005 Apr; 329(2):706-12. PubMed ID: 15737643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphatidylinositol (4,5)-bisphosphate-mediated pathophysiological effect of HIV-1 Tat protein.
    Beaumelle B; Tóth P; Malak OA; Chopard C; Loussouarn G; Vitale N
    Biochimie; 2017 Oct; 141():80-85. PubMed ID: 28549840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infection and replication of Tat- human immunodeficiency viruses: genetic analyses of LTR and tat mutations in primary and long-term human lymphoid cells.
    Chang LJ; Zhang C
    Virology; 1995 Aug; 211(1):157-69. PubMed ID: 7645208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of HIV-1 transcription and virus replication using soluble Tat peptide analogs.
    Kashanchi F; Sadaie MR; Brady JN
    Virology; 1997 Jan; 227(2):431-8. PubMed ID: 9018142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exogenous human immunodeficiency virus type-1 Tat protein selectively stimulates a phosphatidylinositol-specific phospholipase C nuclear pathway in the Jurkat T cell line.
    Zauli G; Previati M; Caramelli E; Bassini A; Falcieri E; Gibellini D; Bertolaso L; Bosco D; Robuffo I; Capitani S
    Eur J Immunol; 1995 Sep; 25(9):2695-700. PubMed ID: 7589147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-Tat Protein Forms Phosphoinositide-dependent Membrane Pores Implicated in Unconventional Protein Secretion.
    Zeitler M; Steringer JP; Müller HM; Mayer MP; Nickel W
    J Biol Chem; 2015 Sep; 290(36):21976-84. PubMed ID: 26183781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
    McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B
    Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting of HIV-1 Tat traffic and function by transduction-competent single chain antibodies.
    Theisen DM; Pongratz C; Wiegmann K; Rivero F; Krut O; Krönke M
    Vaccine; 2006 Apr; 24(16):3127-36. PubMed ID: 16497417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent inhibition of HIV-1 gene expression and TAT-mediated apoptosis in human T cells by novel mono- and multitarget anti-TAT/Rev/Env ribozymes and a general purpose RNA-cleaving DNA-enzyme.
    Unwalla H; Chakraborti S; Sood V; Gupta N; Banerjea AC
    Antiviral Res; 2006 Nov; 72(2):134-44. PubMed ID: 16790281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein transduction domains of HIV-1 and SIV TAT interact with charged lipid vesicles. Binding mechanism and thermodynamic analysis.
    Ziegler A; Blatter XL; Seelig A; Seelig J
    Biochemistry; 2003 Aug; 42(30):9185-94. PubMed ID: 12885253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.